Amoxicillin-Potassium Clavulanate Combination

Clinical Therapeutics
Reduced-Concentration Clavulanate for Young Children with Acute Otitis Media
Alejandro Hoberman, Jack L. Paradise, Howard E. Rockette, Jong-Hyeon Jeong, Diana H. Kearney, Sonika Bhatnagar, Timothy R. Shope, Gysella Muñiz, Judith M. Martin, Marcia Kurs-Lasky, MaryAnn Haralam, Marcia A. Pope, Jennifer P. Nagg, Wenchen Zhao, Mohammad Kowser Miah, Jan Beumer, Raman Venkataramanan, Nader Shaikh
Experimental Therapeutics
Influence of TEM-1 β-Lactamase on the Pharmacodynamic Activity of Simulated Total versus Free-Drug Serum Concentrations of Cefditoren (400 Milligrams) versus Amoxicillin-Clavulanic Acid (2,000/125 Milligrams) against Haemophilus influenzae Strains Exhibiting an N526K Mutation in the ftsI Gene
M. Torrico, L. Aguilar, N. González, M. J. Giménez, O. Echeverría, F. Cafini, D. Sevillano, L. Alou, P. Coronel, J. Prieto
Mechanisms of Resistance
CMT-Type β-Lactamase TEM-125, an Emerging Problem for Extended-Spectrum β-Lactamase Detection
Frédéric Robin, Julien Delmas, Maryse Archambaud, Cédric Schweitzer, Catherine Chanal, Richard Bonnet
Susceptibility
Activities of Tizoxanide and Nitazoxanide Compared to Those of Five Other Thiazolides and Three Other Agents against Anaerobic Species
Glenn A. Pankuch, Peter C. Appelbaum
Clinical Therapeutics
Recovery of Interfering Bacteria in the Nasopharynx following Antimicrobial Therapy of Acute Maxillary Sinusitis with Telithromycin or Amoxicillin-Clavulanate
Itzhak Brook, Jeffrey N. Hausfeld
Experimental Therapeutics
Comparative Bacteriological Efficacy of Pharmacokinetically Enhanced Amoxicillin-Clavulanate against Streptococcus pneumoniae with Elevated Amoxicillin MICs and Haemophilus influenzae
Valerie Berry, Jennifer Hoover, Christine Singley, Gary Woodnutt
Clinical Therapeutics
Efficacy and Safety of Pharmacokinetically Enhanced Amoxicillin-Clavulanate at 2,000/125 Milligrams Twice Daily for 5 Days versus Amoxicillin-Clavulanate at 875/125 Milligrams Twice Daily for 7 Days in the Treatment of Acute Exacerbations of Chronic Bronchitis
Sanjay Sethi, John Breton, Brian Wynne
Clinical Therapeutics
Amoxicillin-Clavulanate Therapy Increases Childhood Nasal Colonization by Methicillin-Susceptible Staphylococcus aureus Strains Producing High Levels of Penicillinase
Didier Guillemot, Stephane Bonacorsi, John S. Blanchard, Philippe Weber, Sylvie Simon, Bruno Guesnon, Edouard Bingen, Claude Carbon
Clinical Therapeutics
Double-Blind, Randomized Study of the Efficacy and Safety of Oral Pharmacokinetically Enhanced Amoxicillin-Clavulanate (2,000/125 Milligrams) versus Those of Amoxicillin-Clavulanate (875/125 Milligrams), Both Given Twice Daily for 7 Days, in Treatment of Bacterial Community-Acquired Pneumonia in Adults
T. M. File, H. Lode, H. Kurz, R. Kozak, H. Xie, E. Berkowitz
and the 600 Study Group
Clinical Therapeutics
Antibacterial Effects of Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae Strains for Which MICs Are High, in an In Vitro Pharmacokinetic Model
Alasdair P. MacGowan, Alan R. Noel, Chris A. Rogers, Karen E. Bowker

Pages